iShares SLI UCITS ETF (DE) (EXI1.DE) is an exchange-traded fund that seeks to track the performance of the SLI® index, comprising the 30 largest and most liquid Swiss companies listed on the SIX Swiss Exchange, through full physical replication by holding all index constituents. The ETF distributes dividends to investors at least annually and maintains a total expense ratio (TER) of 0.51% p.a., with assets under management of approximately EUR 533 million as of recent data. It trades primarily on Xetra and SIX Swiss Exchange in EUR and CHF, respectively, targeting institutional and retail investors seeking exposure to Swiss large-cap equities across sectors including health care (28.24%), financials (27.16%), and industrials (10.92%).
Launched on March 22, 2001, and domiciled in Germany, the ETF is managed by BlackRock Asset Management Deutschland AG, a subsidiary of BlackRock, Inc., with primary operations focused on European markets including Germany, Switzerland, Austria, France, and Italy. Key holdings include UBS Group AG (10.90%), Novartis AG (9.24%), Roche Holding AG (8.55%), Nestlé SA (7.91%), and ABB Ltd. (5.04%), representing over 62% of the portfolio concentrated in Switzerland (93.37%).
Recent developments include sustained asset growth amid strong Swiss market performance, with year-to-date returns of approximately 10.43% and 1-year returns of 5.95% as of late 2025, alongside consistent dividend yields around 1.32-1.38% over the past year. The fund has maintained its distributing policy and physical replication strategy without major structural changes, while BlackRock, its provider, continues expanding its broader ETF lineup through thematic launches such as AI-focused products in collaboration with STOXX in December 2024. No significant acquisitions, partnerships, or operational shifts specific to this ETF have been reported in the last 1-2 years, underscoring its stable role in providing long-term Swiss equity exposure.